Lung Cancer News and Research

Latest Lung Cancer News and Research

UC Davis pioneers advanced PET imaging to monitor lung cancer treatment

Lung cancer can advance quickly. Once a person starts treatment, it is vital to know if that treatment is working or if the patient should be switched to a different treatment.

10 Jun 2024

Lung cancer screening yields early diagnoses and increased cure rates in veterans

Among US veterans diagnosed with lung cancer through the Veterans Health Administration healthcare system, those who underwent screening before diagnosis were more likely to be diagnosed with earlier stage disease and had a higher cure rate than those who had not been screened.

10 Jun 2024

Novel Concepts Medical's plant-based formula achieves 99% reduction in cancer cell viability

Novel Concepts Medical is proud to announce breakthrough results from its labs in Israel showing that its plant-based formula resulted in over 99% decrease in cell viability of breast cancer cells and lung cancer cells.

8 Jun 2024

AI-powered liquid biopsy shows promise in early detection of lung cancer

Using artificial intelligence technology to identify patterns of DNA fragments associated with lung cancer, researchers from the Johns Hopkins Kimmel Cancer Center and other institutions have developed and validated a liquid biopsy that may help identify lung cancer earlier.

6 Jun 2024

Oral insulin drops offer needle-free alternative for diabetes management

Diabetes rates continue to rise, with 11.7 million Canadians living with diabetes or pre-diabetes. At UBC, scientists have created a pain-free drug delivery method to help people with diabetes manage the disease and maintain their health more easily.

5 Jun 2024

Episodic hypoxemia from sleep apnea tied to increased lung cancer relapse

A new study to be presented at the SLEEP 2024 annual meeting is the first to find that episodic hypoxemia and hypoxic burden related to obstructive sleep apnea are associated with the risk of accelerated lung cancer reoccurrence.

4 Jun 2024

Novel combination treatment outperforms standard therapy in patients with EGFR NSCLC

The combination of the antibody amivantamab and lazertinib, a drug targeting EGFR, shows better clinical benefits compared to standard treatment in patients with advanced or metastatic non-small cell lung cancer with EGFR gene mutations who also present one of these poor prognosti markers: brain and/or liver metastases, p53 gene co-mutations, or the presence of circulating tumor DNA.

4 Jun 2024

Research reveals new pathways for treating never-smoker lung cancer

The primary cause of lung cancer is smoking. However, the incidence of lung cancer among never-smokers has been steadily increasing, especially among women.

4 Jun 2024

Researchers show the interplay of socioeconomic status and genetics on disease risk

Differences in socioeconomic status (SES) are known to be linked to differences in the risk of developing disease.

3 Jun 2024

Study reveals disparities in the delivery of cancer-related care at minority serving hospitals

It’s important to ensure that care provided at US hospitals that predominantly serve Black and Hispanic populations is as high-quality as the care provided at other US hospitals. New research reveals significant disparities in the delivery of cancer-related care at minority serving hospitals (MSHs) compared with non-MSHs, however.

3 Jun 2024

New research center delves into ubiquitin's role in cancer

The German Research Foundation (DFG) has now approved a new Collaborative Research Centre in the search for innovative therapies against cancer: Researchers from the Technical University of Munich (TUM), Goethe University Frankfurt and Julius-Maximilians-Universität Würzburg (JMU) have joined forces for this purpose.

31 May 2024

New mobile app shows dramatic success in smoking cessation

A new mobile application, developed under the leadership of researchers from the University of Oulu, Finland, has proven to be an effective aid for long-term smokers attempting to quit.

31 May 2024

Study examines the cost-effectiveness of a targeted immunotherapy for lung cancer

Many countries with national healthcare systems or payers such as insurance companies use cost-effectiveness analyses to decide whether to cover new medicines, balancing treatment costs with potential health benefits.

30 May 2024

New weapon against cancer: "DNA warhead" targets mutant protein in tumor cells

Tumor protein P53 (TP53) plays an important role in suppressing the growth of tumors. Mutations in the gene for TP53 can have a disastrous effect, hampering the body's ability to fight tumors and even encouraging their growth.

29 May 2024

Targeting CD47 to improve osimertinib efficacy in EGFR mutant NSCLC

NSCLC is the leading cause of cancer deaths globally, with EGFR mutations being a common feature in these cancers.

28 May 2024

Study reveals cancer treatment disparities at minority-serving hospitals

It’s important to ensure that care provided at US hospitals that predominantly serve Black and Hispanic populations is as high-quality as the care provided at other US hospitals.

27 May 2024

AI-based body composition analysis predicts lung cancer treatment outcomes

Tafadzwa Chaunzwa, MD, a researcher in the Artificial Intelligence in Medicine (AIM) Program at Mass General Brigham and a senior resident physician at the Harvard Radiation Oncology Program, is the lead author of a paper published in JAMA Oncology.

24 May 2024

Physician-pharmacy integration not associated with change in the care of cancer patients

Integration of pharmacies with physician practices, where on-site pharmacies open at physician practice locations, is a growing trend in cancer treatment.

23 May 2024

New AI model sets benchmark in digital pathology with superior cancer diagnostics

Researchers developed Prov-GigaPath, a whole-slide pathology foundation model using a novel vision transformer architecture. The model demonstrates superior performance in mutation prediction, cancer subtyping, and vision-language tasks. It leverages large-scale real-world data from over 30,000 patients to enhance clinical diagnostics.

23 May 2024

Gene cluster expression analysis for personalized lung cancer therapy

About 30% of lung cancer patients are accessible to targeted therapy or immunotherapy based on the current criteria.

23 May 2024

Lung Cancer News and Research

Latest Lung Cancer News and Research

UC Davis pioneers advanced PET imaging to monitor lung cancer treatment

Lung cancer screening yields early diagnoses and increased cure rates in veterans

Novel Concepts Medical's plant-based formula achieves 99% reduction in cancer cell viability

AI-powered liquid biopsy shows promise in early detection of lung cancer

Oral insulin drops offer needle-free alternative for diabetes management

Episodic hypoxemia from sleep apnea tied to increased lung cancer relapse

Novel combination treatment outperforms standard therapy in patients with EGFR NSCLC

Research reveals new pathways for treating never-smoker lung cancer

Researchers show the interplay of socioeconomic status and genetics on disease risk

Study reveals disparities in the delivery of cancer-related care at minority serving hospitals

New research center delves into ubiquitin's role in cancer

New mobile app shows dramatic success in smoking cessation

Study examines the cost-effectiveness of a targeted immunotherapy for lung cancer

New weapon against cancer: "DNA warhead" targets mutant protein in tumor cells

Targeting CD47 to improve osimertinib efficacy in EGFR mutant NSCLC

Study reveals cancer treatment disparities at minority-serving hospitals

AI-based body composition analysis predicts lung cancer treatment outcomes

Physician-pharmacy integration not associated with change in the care of cancer patients

New AI model sets benchmark in digital pathology with superior cancer diagnostics

Gene cluster expression analysis for personalized lung cancer therapy

The ultimate guide to lung research tools and protocols eBook

The evolution of OCT for retinal imaging and disease intervention

Supercharging Next-Gen Antibody Discovery with AI and High-Throughput Experimentation

Prof. Dr. Kristina Kusche-Vihrog

Lung Cancer News and Research

Latest Lung Cancer News and Research

The ultimate guide to lung research tools and protocols eBook

The evolution of OCT for retinal imaging and disease intervention

Supercharging Next-Gen Antibody Discovery with AI and High-Throughput Experimentation

Prof. Dr. Kristina Kusche-Vihrog

Newsletters you may be interested in